PARP inhibitors: what we know and what we have yet to know

Oncology (Williston Park). 2010 Jan;24(1):62, 65-6.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA1 Protein / metabolism
  • BRCA2 Protein / genetics
  • BRCA2 Protein / metabolism
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / genetics
  • Clinical Trials as Topic
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Humans
  • Poly(ADP-ribose) Polymerases / physiology*

Substances

  • BRCA1 Protein
  • BRCA2 Protein
  • Enzyme Inhibitors
  • Poly(ADP-ribose) Polymerases